First, we investigated the correlation between CDK6 and p-ERK staining intensity levels in baseline tumor samples and PFS, as in our initial study we found that the tumor models with higher activity of those signaling nodes were the most sensitive to the combination. This evidence concerns the gene CDK6 and neoplasm.